Funding for this research was provided by:
Læge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat
Fonden til Lægevidenskabens Fremme
Received: 29 April 2020
Accepted: 12 August 2020
First Online: 4 September 2020
Ethics approval and consent to participate
: All participants gave written informed consent before participation in the study. The study was approved by the Health Research Ethics Committee for the Capital Region of Denmark (H-16038786) and the Danish Data Protection Agency (AHH-2016-067).
: Not applicable.
: O.A. is inventor of the patent on suPAR and prognosis. Hvidovre Hospital, Denmark, owns the patent which is licensed to ViroGates A/S. J.T., L.J.H.R, M.B.H., A.L.A, I. P, J.P. A.L., and J.O.N. declare that they have no competing interests.